Escitalopram Oxalate

• CAT Number: A000710
• CAS Number: 219861-08-2
• Molecular Formula: C22H23FN2O5
• Molecular Weight: 414.43
• Purity: ≥95%
• Synonyms: 219861-08-2; Lexapro; Cipralex; (S)-Citalopram Oxalate; Escitalopram (oxalate)
• Target: SSRIs
• Solubility: Soluble in DMSO > 10 mM
• Storage: -20°C
• InChI: 1S/C20H21FN2O.C2H2O4/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20;3-1(4)2(5)6/h4-9,12H,3,10-11,14H2,1-2H3;(H,3,4)(H,5,6)/t20-;/m0./s1
• InChIKey: KTGRHKOEFSJQNS-BDQAORGHSA-N
• SMILES: CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.C(=O)(C(=O)O)O

Escitalopram oxalate (Cat. No: A000710) is a new type of SSRIS drug, which mainly mediates the inhibitory effect of citalopram on 5-HT reuptake, and has a high affinity for low affinity allosteric binding sites. It has become the first-line drug for the treatment of depression by inhibiting 5-HT transporter (SERT) in a highly selective dose-dependent manner and inhibiting 5-HT reuptake in the presynaptic membrane of nerve endings in the central nervous system.

Reference

1: Chen VC, Hsieh YH, Chen LJ, Hsu TC, Tzang BS. Escitalopram oxalate induces
apoptosis in U-87MG cells and autophagy in GBM8401 cells. J Cell Mol Med. 2017
Nov 3. doi: 10.1111/jcmm.13372. [Epub ahead of print] PubMed PMID: 29105282.

2: Attia K Ali, Mohamed AM, Fekry MA. Electroanalytical Determination of
Escitalopram Oxalate Using Nickel Nanoparticles Modified Carbon Paste Sensor.
Acta Chim Slov. 2017 Jun;64(2):415-421. PubMed PMID: 28621385.

3: Sheladia S, Patel B. Determination of Escitalopram Oxalate and L-Methylfolate
in Tablet by Spectrophotometric and Reverse Phase High-Performance Liquid
Chromatographic Methods. J Chromatogr Sci. 2017 May 1;55(5):550-555. doi:
10.1093/chromsci/bmx008. PubMed PMID: 28203815.

4: Ma L, Lu ZN, Hu P, Yao CJ. Neuroprotective effect of escitalopram oxalate in
rats with chronic hypoperfusion. J Huazhong Univ Sci Technolog Med Sci. 2015
Aug;35(4):514-8. doi: 10.1007/s11596-015-1462-x. Epub 2015 Jul 31. PubMed PMID:
26223919.

5: Khanna S, Chirinos RE, Venna S. Escitalopram oxalate (Lexapro)-induced
acneiform eruption. J Am Acad Dermatol. 2012 Dec;67(6):e261-3. doi:
10.1016/j.jaad.2012.03.032. PubMed PMID: 23158626.

6: Kakde RB, Satone DD, Gadapayale KK, Kakde MG. Stability-indicating RP-HPLC
method for the simultaneous determination of escitalopram oxalate and clonazepam.
J Chromatogr Sci. 2013 Jul;51(6):490-5. doi: 10.1093/chromsci/bms177. Epub 2012
Nov 7. PubMed PMID: 23135233.

7: Alarfaj NA, Aly FA, Al-Qahtany AA. Flow-injection chemiluminescence and
electrogenerated chemiluminescence determination of escitalopram oxalate in
tablet form. Luminescence. 2013 Jan-Feb;28(1):84-92. doi: 10.1002/bio.2372. Epub
2012 May 4. PubMed PMID: 22555899.

8: Dikmen M, Cantürk Z, Oztürk Y. Escitalopram oxalate, a selective serotonin
reuptake inhibitor, exhibits cytotoxic and apoptotic effects in glioma C6 cells.
Acta Neuropsychiatr. 2011 Aug;23(4):173-8. doi: 10.1111/j.1601-5215.2011.00550.x.
PubMed PMID: 25379795.

9: Sharma S, Rajpurohit H, Sonwal C, Bhandari A, Choudhary V, Jain T. Zero order
spectrophotometric method for estimation of escitalopram oxalate in tablet
formulations. J Young Pharm. 2010 Oct;2(4):420-3. doi: 10.4103/0975-1483.71626.
PubMed PMID: 21264107; PubMed Central PMCID: PMC3019386.

10: Vetrichelvan T, Arul K, Sumithra M, Umadevi B. Colorimetric method for the
estimation of escitalopram oxalate in tablet dosage form. Indian J Pharm Sci.
2010 Mar;72(2):269-71. doi: 10.4103/0250-474X.65011. PubMed PMID: 20838541;
PubMed Central PMCID: PMC2929796.